期刊
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL
卷 94, 期 6, 页码 875-880出版社
FERRATA STORTI FOUNDATION
DOI: 10.3324/haematol.2008.002691
关键词
non-Hodgkin's lymphoma; HIV; immunosuppression; CD4 count; cohort study
类别
资金
- Medical Research Council, UK [G0000199, G0600337]
- MRC [G0600337, G0200585, MC_U122886351] Funding Source: UKRI
- Medical Research Council [MC_U122886351, G0600337, G0200585] Funding Source: researchfish
Since the introduction of highly active antiretroviral therapy, there has been a decline in the incidence of non-Hodgkin's lymphoma among HIV-infected individuals. We described trends in the incidence of systemic non-Hodgkin's lymphoma in the UK CHIC Study from 19962006 and evaluated the association between immunosuppression and development of systemic non-Hodgkin's lymphoma: 286/23,155 (1.2%) individuals developed an AIDS-defining lymphoma (258 systemic). Younger age, receipt of highly active antiretroviral therapy and later calendar year were all independently associated with a reduced risk of systemic non-Hodgkin's lymphoma. A lower latest CD4 count was strongly associated with systemic non-Hodgkin's lymphoma, in patients who had (RR per log(2)(cells/mm(3)) higher: 0.62) and had not (0.70) received highly active antiretroviral therapy. Associations with other measures of immunosuppression, including nadir CD4 count, experience and duration of severe immunosuppression, were generally weaker. Earlier highly active antiretroviral therapy initiation and wider access to HIV testing is advocated to reduce the risk of systemic non-Hodgkin's lymphoma.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据